Arvinas Correlations
ARVN Stock | USD 25.86 0.75 2.99% |
The current 90-days correlation between Arvinas and Nurix Therapeutics is 0.4 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Arvinas Correlation With Market
Very weak diversification
The correlation between Arvinas and DJI is 0.53 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and DJI in the same portfolio, assuming nothing else is changed.
Arvinas |
Moving together with Arvinas Stock
Moving against Arvinas Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Arvinas Stock performing well and Arvinas Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arvinas' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CCCC | 3.70 | (0.61) | 0.00 | (0.28) | 0.00 | 9.57 | 23.66 | |||
GLUE | 5.33 | 0.74 | 0.22 | 0.34 | 3.86 | 10.11 | 102.66 | |||
NRIX | 2.57 | (0.24) | 0.00 | (0.01) | 0.00 | 6.17 | 22.77 | |||
FHTX | 4.06 | (0.21) | 0.02 | 0.06 | 4.43 | 8.50 | 34.64 | |||
RLAY | 3.45 | (0.83) | 0.00 | (0.09) | 0.00 | 4.82 | 66.18 | |||
STOK | 2.63 | (0.38) | 0.00 | (0.17) | 0.00 | 4.68 | 21.35 | |||
PLRX | 2.71 | (0.23) | (0.03) | 0.02 | 3.19 | 5.37 | 24.35 | |||
BDTX | 3.64 | (1.52) | 0.00 | (0.52) | 0.00 | 5.56 | 19.51 | |||
STTK | 4.98 | (1.61) | 0.00 | (0.61) | 0.00 | 7.03 | 52.02 | |||
KYMR | 2.39 | (0.24) | (0.04) | 0.00 | 3.09 | 4.84 | 18.10 |
Arvinas Corporate Management
CPA CPA | CFO Treasurer | Profile | |
Ian Taylor | Chief Scientific Officer | Profile | |
Paul McInulty | Senior Affairs | Profile | |
Matthew JD | Gen Sec | Profile | |
John Grosso | Senior Operations | Profile | |
Randy Teel | Senior Development | Profile |